What was the market valuation of the UK laxatives market in 2024?

The market valuation of the UK laxatives market was $273.75 Million in 2024. Read More

What is the projected market valuation for the UK laxatives market by 2035?

The projected market valuation for the UK laxatives market is $586.0 Million by 2035. Read More

What is the expected CAGR for the UK laxatives market during the forecast period 2025 - 2035?

The expected CAGR for the UK laxatives market during the forecast period 2025 - 2035 is 7.16%. Read More

Which drug type segment is projected to have the highest valuation in 2035?

The Stimulants segment is projected to have the highest valuation, reaching $256.0 Million by 2035. Read More

How does the valuation of the Oral route of administration compare to the Rectal route in 2024?

In 2024, the Oral route of administration was valued at $164.625 Million, while the Rectal route was valued at $109.125 Million. Read More

What is the projected valuation for the Chronic Constipation indication by 2035?

The projected valuation for the Chronic Constipation indication is $220.0 Million by 2035. Read More

Which end user segment is expected to grow the most by 2035?

The Others end user segment is expected to grow the most, reaching $324.25 Million by 2035. Read More

What was the valuation of the Bulk-Forming drug type segment in 2024?

The Bulk-Forming drug type segment was valued at $50.0 Million in 2024. Read More

How does the market for Irritable Bowel Syndrome compare to other indications in 2035?

By 2035, the market for Irritable Bowel Syndrome is projected to reach $160.0 Million, indicating substantial growth compared to other indications. Read More

UK Laxatives Market

Q: What are the key players in the UK laxatives market?

Key players in the UK laxatives market include Bayer AG, Johnson & Johnson, Procter & Gamble Co, Abbott Laboratories, GlaxoSmithKline plc, Sanofi S.A., Pfizer Inc., and Novartis AG. Read More

ID: MRFR/HC/43482-HCR

200 Pages

Satyendra Maurya

Last Updated: April 06, 2026

UK Laxatives Market Research Report By Route of Administration (Oral, Rectal), By Indication (Chronic Constipation, Irritable Bowel Syndrome, Others), By Drug Type (Hyperosmotic, Bulk-Forming, Stool Softeners, Lubricants, Stimulants) and By End User (Hospitals Clinics, Research Institutes, Others) - Growth & Industry Forecast 2025 To 2035

UK Laxatives Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)7.16%

2024 Market Size$ 273.75 Million

2025 Market Size$ 293.35 Million

2035 Market Size$ 586 Million

Key Players

Bayer AG

Johnson & Johnson

Procter & Gamble Co

Abbott Laboratories

GlaxoSmithKline plc

Sanofi S.A.

Trends

Rising Demand for Natural Laxatives
Increased Focus on Digestive Health
Aging Population Driving Market Growth

Opportunities

Rising Healthcare Expenditure
Expansion of E-commerce Platforms
Innovations in Product Formulations

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Route of Administration (USD Million)
  1. 4.1.1 Oral
  2. 4.1.2 Rectal
2. 4.2 Healthcare, BY Indication (USD Million)
  1. 4.2.1 Chronic Constipation
  2. 4.2.2 Irritable Bowel Syndrome
  3. 4.2.3 Others
3. 4.3 Healthcare, BY Drug Type (USD Million)
  1. 4.3.1 Hyperosmotic
  2. 4.3.2 Bulk-Forming
  3. 4.3.3 Stool Softeners
  4. 4.3.4 Lubricants
  5. 4.3.5 Stimulants
4. 4.4 Healthcare, BY End User (USD Million)
  1. 4.4.1 Hospitals & Clinics
  2. 4.4.2 Research Institutes
  3. 4.4.3 Others
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Bayer AG (DE)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Johnson & Johnson (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Procter & Gamble Co (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Abbott Laboratories (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 GlaxoSmithKline plc (GB)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Sanofi S.A. (FR)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Pfizer Inc. (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Novartis AG (CH)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 UK MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
3. 6.3 UK MARKET ANALYSIS BY INDICATION
4. 6.4 UK MARKET ANALYSIS BY DRUG TYPE
5. 6.5 UK MARKET ANALYSIS BY END USER
6. 6.6 KEY BUYING CRITERIA OF HEALTHCARE
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF HEALTHCARE
9. 6.9 DRIVERS IMPACT ANALYSIS: HEALTHCARE
10. 6.10 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
11. 6.11 SUPPLY / VALUE CHAIN: HEALTHCARE
12. 6.12 HEALTHCARE, BY ROUTE OF ADMINISTRATION, 2024 (% SHARE)
13. 6.13 HEALTHCARE, BY ROUTE OF ADMINISTRATION, 2024 TO 2035 (USD Million)
14. 6.14 HEALTHCARE, BY INDICATION, 2024 (% SHARE)
15. 6.15 HEALTHCARE, BY INDICATION, 2024 TO 2035 (USD Million)
16. 6.16 HEALTHCARE, BY DRUG TYPE, 2024 (% SHARE)
17. 6.17 HEALTHCARE, BY DRUG TYPE, 2024 TO 2035 (USD Million)
18. 6.18 HEALTHCARE, BY END USER, 2024 (% SHARE)
19. 6.19 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Million)
  2. 7.2.2 BY INDICATION, 2025-2035 (USD Million)
  3. 7.2.3 BY DRUG TYPE, 2025-2035 (USD Million)
  4. 7.2.4 BY END USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

UK UK Laxatives Market Segmentation

UK Laxatives Market By Route of Administration (USD Million, 2025-2035)

Oral
Rectal

UK Laxatives Market By Indication (USD Million, 2025-2035)

Chronic Constipation
Irritable Bowel Syndrome
Others

UK Laxatives Market By Drug Type (USD Million, 2025-2035)

Hyperosmotic
Bulk-Forming
Stool Softeners
Lubricants
Stimulants

UK Laxatives Market By End User (USD Million, 2025-2035)

Hospitals & Clinics
Research Institutes
Others

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”